Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Quality Assurance01:19

Quality Assurance

929
Quality assurance is the overarching term used to describe the activities employed to ensure the proper performance of a system. These activities can be classified into three categories: quality control, quality assessment, and internal corrective measures. Typically, these activities work cyclically: quality control is performed before and during the analysis, while quality assessment occurs during and after the investigation. Internal corrective measures are implemented based on the findings...
929
Genomic Imprinting and Inheritance02:30

Genomic Imprinting and Inheritance

36.7K
Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
36.7K
Intellectual Disability01:29

Intellectual Disability

595
Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
595

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploratory Economic Evaluation of a Genome Precision Report in Kidney and Liver Transplantation Care.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
Same author

Automated reanalysis of genomic data for rare disease diagnostics at scale.

Nature medicine·2026
Same author

Gene-disease relationships for glomerular phenotypes: expert recommendations from ClinGen.

Nature reviews. Nephrology·2026
Same author

Genomic Newborn Screening: Verdict From an Australian Citizens' Jury.

The Medical journal of Australia·2026
Same author

'Missing' disease-causing variants in Alport syndrome.

Nature reviews. Nephrology·2026
Same author

Expanding the paradigm of the recurrent mosaic SMO c.1234C>T variant: a linear blaschkoid congenital lesion with multiple basal cell carcinomas.

Clinical and experimental dermatology·2025

Related Experiment Video

Updated: Jan 8, 2026

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
09:30

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform

Published on: August 17, 2022

3.5K

Piloting an Interpretive External Quality Assurance Model for Genomic Testing for Childhood Syndromes and

Ben Lundie1, Sze Yee Chai2, Alicia B Byrne3

  • 1Pathology Queensland, Brisbane, Queensland, Australia; Institute for Medical Bioscience, University of Queensland, St Lucia, Queensland, Australia.

The Journal of Molecular Diagnostics : JMD
|December 20, 2025
PubMed
Summary

A pilot program assessed genomic testing interpretation for pediatric disorders. Laboratories showed proficiency in variant identification but varied in reporting, highlighting the need for specialized quality assurance in genomic diagnostics.

More Related Videos

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
05:51

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

Published on: June 15, 2011

26.3K
In Vivo Modeling of the Morbid Human Genome using Danio rerio
12:31

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

21.2K

Related Experiment Videos

Last Updated: Jan 8, 2026

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
09:30

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform

Published on: August 17, 2022

3.5K
A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
05:51

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

Published on: June 15, 2011

26.3K
In Vivo Modeling of the Morbid Human Genome using Danio rerio
12:31

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

21.2K

Area of Science:

  • Genomic Medicine
  • Clinical Diagnostics
  • Quality Assurance

Background:

  • Large-scale human genome and exome analysis require robust external quality assurance (EQA) programs.
  • Existing EQA programs often lack the specificity for complex genomic testing in pediatric disorders.

Purpose of the Study:

  • To develop and pilot a disease-specific interpretive module for genomic testing in childhood syndromes and intellectual disabilities.
  • To assess laboratory proficiency in interpreting complex genomic data for pediatric conditions.

Main Methods:

  • Six accredited laboratories analyzed standardized genomic, phenotypic, and referral data for pediatric cases.
  • Reports were evaluated using a rubric based on the European Molecular Genetics Quality Network model, assessing genotyping, variant classification, and interpretation.
  • Feedback included comparative performance and individual recommendations.

Main Results:

  • All participating laboratories accurately identified and classified target variants.
  • Variations were noted in report structure, genetic counseling advice, and the application of the American College of Medical Genetics and Genomics/Association for Molecular Pathology classification framework.
  • Data-sharing limitations and differing local practices influenced scoring consistency.

Conclusions:

  • The pilot demonstrated the feasibility of a specialized interpretive Quality Assurance Program (QAP) for pediatric genomic testing.
  • Refinements in logistics, scoring, and standardization are planned for future rounds.
  • This initiative supports improved diagnostic accuracy and consistency in clinical genomic laboratories.